Ira Ehrenpreis - Profile and Investment Details

Investor Profile

Ira Ehrenpreis is a Venture Capital based in Palo Alto, California, United States with a diverse investment portfolio that includes companies such as Stanford University, Visiogen, Fiber Global, Airspace, Abound Solar, Springboard Enterprises, NACD (National Association of Corporate Directors), TRIA Beauty, TheZero Inc., Incline Therapeutics, APX, Elcelyx Therapeutics, Farmer's Business Network, Inc., AllAdvantage, Nfocus Neuromedical, Andela, Eloan, Benvenue Medical, Scioderm, The RealReal, R-Zero, CoalTek, BrainCells, San Jose Earthquakes Soccer, Datria Systems, BurnBot, Apeel, Alta Devices, National Renewable Energy Laboratory, Akros Silicon, EmSense, National Venture Capital Association, eNeura Therapeutics, Menlo Micro, SpaceX, Planet., Leptos Biomedical, Kaiam, Tesla Motors, Spatial, NanoGram, Zola Electric, Revance Therapeutics, BioTrove, Mapbox, Medley Health, ForSight Labs, Transcend Medical, NightFire Software, Encirq Corporation, Accelergy, NeuroPace, Beamreach, Imagicast, Storability Software, ForSight VISION5, Saegis Pharmaceuticals, Terram Lab, ITM Software, Sensicore, SkillsVillage, . Over time, Ira Ehrenpreis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ira Ehrenpreis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Energy, Education, Retail, Wholesale, Manufacturing, Biotechnology, Innovation, Health Diagnostics, Renewable Energy, Medical, Pharmaceuticals, Recycling may find it worthwhile to explore potential connections with Ira Ehrenpreis, as their portfolio suggests a familiarity and interest in this area.

Understanding Ira Ehrenpreis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.